This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Pediatric Obesity
Information about Pediatric Obesity: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Pediatric Obesity
Most recent studies have shown that Pediatric Obesity shares some biological mechanisms with atherosclerosis, cardiovascular-diseases, depressive-disorder, diabetes-mellitus, diabetes-mellitus-non-insulin-dependent, dyslipidemias, fatty-liver, heart-diseases, hyperinsulinism, hypertensive-disease, impaired-glucose-tolerance, inflammation, insulin-resistance, insulin-sensitivity, metabolic-syndrome-x, obesity, obesity-morbid, sleep-apnea-syndromes.
Among the many pathways, these few ones have gauged particular interests from scientists studying Pediatric Obesity, and have been seen in publications frequently: Adipose Tissue Development, Bone Development, Coagulation, Cognition, Eating Behavior, Energy Homeostasis, Excretion, Fatty Acid Oxidation, Feeding Behavior, Glucose Homeostasis, Insulin Secretion, Lactation, Menarche, Parental Behavior, Pathogenesis, Secretion, Swimming, Tissue Development, Translation, Transport
Quite a number of genes have been found to play important roles in Pediatric Obesity, such as ADIPOQ, AMY2A, BLOC1S6, CRP, EPB42, FTO, IGF1, IL6, INS, LEP, MC4R, NDUFB6, POMC, PRH1, RANGAP1, SLC17A5, TG, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.